length

(redirected from cervical length)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia.

length

noun breadth, continuance, dimension, distance lengthwise, elongation, expanse, expansion, extensiveness, extent, lengthiness, limit, long-windedness, magnitude, measure, measurement, proportion, range, reach, size, span, stretch
Associated concepts: length of memoranda of law, term limit
References in periodicals archive ?
Transvaginal ultrasound (TVU) cervical length (CL) screening for prediction and prevention of spontaneous preterm birth (SPTB) is among the most transformative clinical changes in obstetrics in the last decades.
Argyelan noted that the current Society for Maternal-Fetal Medicine (SMFM) position regarding cervical length screening is that it should not yet be universally mandated for singleton pregnancies without a prior history of preterm birth.
Secondary outcomes of interest included cervical length at 2 weeks after the start of treatment, neonatal outcomes, complications, and route of delivery.
Combined fetal fibronectin and cervical length and spontaneous preterm birth in asymptomatic triplet pregnancies.
We analyzed five variables: sex, previous fibroscopy, cervical length (<5 cm, 5.
Such studies (39-41) led to the more recent ACOG Practice Bulletin in 2012 recognizing the utility of routine second trimester cervical length evaluation even in low risk populations.
According to Columbia Laboratories Inc, Prochieve has been filed by Watson with New Drug Application (NDA 22-139) for the prevention of preterm birth in women with a short cervical length.
Material and Method: Patients with singleton pregnancy having a history of one or more second trimester losses were selected on the basis of history, physical examination and ultrasound assessment of cervical length with a cut off of 2.
The risk factors for cervical incompetence include recurrent mid trimester losses, previous pre-term pre-mature rupture of membranes before 32 weeks, cervical length of less than 25mm prior to 27 weeks and prior cervical trauma (e.
23 January 2012 - Columbia Laboratories Inc (NASDAQ:CBRX) and Watson Pharmaceuticals Inc (NYSE:WPI) said on Friday that the US Food and Drug Administration's (FDA) Advisory Committee for Reproductive Health Drugs came up with a negative opinion on the approval of progesterone vaginal gel 8% for the reduction of risk of preterm birth in women with short uterine cervical length at the mid-trimester of pregnancy.

Full browser ?